Episode Details

IQVIA’s stock surged nearly 6% after Baird upgraded its rating to “Outperform” and slapped it with a “bullish Fresh Pick” label, citing strong earnings and AI-driven growth momentum. Despite a volatile year marked by 11 five-percent swings, the company beat Q2 revenue and EPS forecasts, fueled by robust growth in its Technology & Analytics Solutions division. IQVIA also slightly raised its 2025 EPS outlook, reinforcing investor confidence as demand for its clinical research and data services remains resilient — even as the stock lags its 2026 highs and declines over 9% this year.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c919aa1bd3736756